Add BrightSurf on Google Email

Self-administered hypnosis vs sham hypnosis for hot flashes

A randomized clinical trial found that self-administered hypnosis significantly reduced hot flash scores and daily interference compared to sham hypnosis. The study suggests that hypnosis delivered through audio files is a clinically significant method for reducing hot flashes in postmenopausal women.

SourceJAMA Network·JournalJAMA Network Open·DateNov 11, 2025

Home training for cerebellar ataxias

Home high-intensity aerobic training outperforms home balance training in improving ataxia symptoms, fatigue, and aerobic fitness among those with cerebellar ataxias. Regular training maintained benefits at 1 year.

SourceJAMA Network·JournalJAMA Neurology·DateSep 14, 2025

Acupuncture for chronic low back pain in older adults

A randomized clinical trial found that acupuncture provided greater improvements in back pain-related disability compared to usual medical care alone. The study suggests that acupuncture needling is an effective and safe treatment option for older adults with chronic low back pain.

SourceJAMA Network·JournalJAMA Network Open·DateSep 12, 2025

Hepatitis C screening in emergency departments

A new study found that a nontargeted screening approach can identify more patients with hepatitis C virus infections than traditional targeted screening methods. The results highlight the need for improved treatment models, as patients who went from diagnosis to sustained virologic response increased significantly.

SourceJAMA Network·JournalJAMA·DateJul 9, 2025

Varenicline for youth nicotine vaping cessation

A 12-week randomized clinical trial shows varenicline combined with behavioral counseling effectively increased vaping abstinence in youth who vape nicotine but do not regularly smoke tobacco. This study provides hope for a novel treatment approach to help combat the growing youth vaping epidemic.

SourceJAMA Network·JournalJAMA·DateApr 23, 2025

Cardioprotective glucose-lowering agents and dementia risk

A meta-analysis of randomized clinical trials found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a statistically significant reduction in all-cause dementia. Cardioprotective glucose-lowering therapies, however, did not show an overall reduction in dementia risk.

SourceJAMA Network·JournalJAMA Neurology·DateApr 7, 2025

Smartwatches may help control diabetes through exercise

A new study found that smartwatches paired with a health app can encourage people with newly diagnosed Type 2 Diabetes to start and maintain purposeful exercise, leading to improvements in blood sugar levels and systolic blood pressure. The programme also helped participants lower cholesterol and improve their quality of life.

SourceUniversity of Birmingham·JournalBMJ Open·TypeObservational study·DateMar 26, 2025

Early surgical intervention in children with sleep-disordered breathing reduces need for doctor visits, prescriptions

A randomized trial found that adenotonsillectomy surgery reduced healthcare utilization in children with mild sleep-disordered breathing by 32% fewer doctor visits and 48% fewer prescriptions. This effective early intervention supports reducing behavioral, neurocognitive, cardiovascular, and cardiometabolic issues.

SourceBrigham and Women's Hospital·JournalJAMA Pediatrics·TypeObservational study·DateMar 17, 2025

Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer—insights from two-sample Mendelian randomization study and meta-analysis

A genetic predisposition to type II diabetes mellitus is associated with a reduced risk of esophageal cancer. Metformin use has been shown to decrease the prevalence of esophageal cancer, while insulin and gliclazide have no significant association.

SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateFeb 25, 2025

Paxlovid’s impact on hospitalization and death in COVID-vaccinated older adults far weaker than previously thought

New UCLA-led research finds that Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study suggests that Paxlovid's potential effect on COVID-19 hospitalization in vaccinated older adults is four times weaker than originally reported.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA·TypeData/statistical analysis·DateFeb 20, 2025

Preventing transition to substance use disorders in teenagers: brief cognitive behavioural program PreVenture shows promising results

A cluster randomized trial involving 31 Canadian high schools and 3,800 students found that delivering personality-targeted brief cognitive behavioral interventions to students in the 7th grade reduced risk for substance use disorders by the end of high school. The intervention was associated with a 23%-80% reduced odds of SUD compared...

SourceUniversity of Montreal·JournalAmerican Journal of Psychiatry·DateJan 16, 2025